Autism Studies and Related Medical Conditions, January 2009 - TACA

More documents

Recommendations

Info

Vaqta Merck & Co, Inc 0 0 HepA/HepB Twinrix GlaxoSmithKline Biologicals < 0.0002% < 1 µg/1mL dose IPV IPOL Sanofi Pasteur, SA 0 0 Poliovax Sanofi Pasteur, Ltd 0 0 Influenza Afluria CSL Limited 0 (single dose) 0.01% (multidose) 0/0.5 mL (single dose) 24.5 µg/0.5 mL (multidose) Fluzone 6 Sanofi Pasteur, Inc 0.01% 25 µg/0.5 mL dose Fluvirin Novartis Vaccines and Diagnostics Ltd 0.01% 25 µg/0.5 ml dose Fluzone (no thimerosal) Sanofi Pasteur, Inc 0 0 Fluvirin (Preservative Free) Novartis Vaccines and Diagnostics Ltd < 0.0004% < 1 µg/0.5 mL dose Fluarix GlaxoSmithKline Biologicals < 0.0004% < 1 µg/0.5 ml dose FluLaval ID Biomedical Corporation of Quebec 0.01% 25 µg/0.5 ml dose Autism Studies & Related Medical Conditions – TACA © Page 370
Influenza, live FluMist MedImmune Vaccines, Inc 0 0 Japanese Encephalitis 7 JE-VAX Research Foundation for Microbial Diseases of Osaka University 0.007% 35 µg/1.0mL dose 17.5 µg/0.5 mL dose MMR MMR-II Merck & Co, Inc 0 0 Meningococcal Menomune A, C, AC and A/C/Y/W- 135 Sanofi Pasteur, Inc 0.01% (multidose) 0 (single dose) 25 µg/0.5 dose 0 Menactra A, C, Y and W-135 Sanofi Pasteur, Inc 0 0 Pneumococcal Prevnar (Pneumo Conjugate) Wyeth Pharmaceuticals Inc 0 0 Pneumovax 23 Merck & Co, Inc 0 0 Rabies IMOVAX Sanofi Pasteur, SA 0 0 Rabavert Novartis Vaccines and Diagnostics 0 0 Smallpox (Vaccinia), Live ACAM2000 Acambis, Inc. 0 0 Typhoid Fever Typhim Vi Sanofi Pasteur, SA 0 0 Autism Studies & Related Medical Conditions – TACA © Page 371
Page 1 and 2:
Autism Studies & Related Medical Co
Page 3 and 4:
Values of free and total carnitine
Page 5 and 6:
observation suggests that certain m
Page 7 and 8:
with autism. These data suggest tha
Page 9 and 10:
Markers rs2056202 and rs2292813 wer
Page 11 and 12:
2- Autism and Gastrointestinal Infl
Page 13 and 14:
than in nondisease controls (p
Page 15 and 16:
Buie, T. M. (2005). "Gastroesophage
Page 17 and 18:
control children and significant nu
Page 19 and 20:
Horvath, K. and J. A. Perman (2002)
Page 21 and 22:
components indicates a role of NFH
Page 23 and 24:
patients with Crohn disease, one of
Page 25 and 26:
analyzed by a registered pediatric
Page 27 and 28:
oligonucleotide probes targeting pr
Page 29 and 30:
would be effective in alleviating c
Page 31 and 32:
demonstrate a focal CD8-dominated g
Page 33 and 34:
Chlamydia pneumoniae and Streptococ
Page 35 and 36:
vaccine (MCV), and once-exposed chi
Page 37 and 38:
Wakefield, A. J., S. H. Murch, et a
Page 39 and 40:
Walker SJ, Hepner K, Segal J, Krigs
Page 41 and 42:
R, Maisawa S, Miki K. Guidelines fo
Page 43 and 44:
approximately 73 and 37kDa in plasm
Page 45 and 46:
Cook, E. H., Jr., B. D. Perry, et a
Page 47 and 48:
evealed, that AAb level may serve a
Page 49 and 50:
findings, which consisted of obstru
Page 51 and 52:
angiography was performed in all fo
Page 53 and 54:
matched non-autistic siblings had d
Page 55 and 56:
Todd, R. D. and R. D. Ciaranello (1
Page 57 and 58:
eaction was further confirmed by DO
Page 59 and 60:
asic protein (MBP) and glial acidic
Page 61 and 62:
exhibit higher than average levels
Page 63 and 64:
Feasby, T., B. Banwell, et al. (200
Page 65 and 66:
each group participated. Observatio
Page 67 and 68:
Rossignol, D. A., L. W. Rossignol,
Page 69 and 70:
Tsuru, T., M. Mori, et al. (2000).
Page 71 and 72:
Anderson, M. P., B. S. Hooker, et a
Page 73 and 74:
continue. The documented prevalence
Page 75 and 76:
contributing factors may contribute
Page 77 and 78:
Chauhan, V., A. Chauhan, et al. (20
Page 79 and 80:
and folate-dependent methionine syn
Page 81 and 82:
confirmed would indicate that autis
Page 83 and 84:
differed significantly in the patie
Page 85 and 86:
end products (AGE's) in autism brai
Page 87 and 88:
cells in area 22 (p
Page 89 and 90:
nutritional, and toxic status in au
Page 91 and 92:
increase in autism in the last deca
Page 93 and 94:
morphological, genetic and animal m
Page 95 and 96:
Rossignol, D. A. (2007). "Hyperbari
Page 97 and 98:
conditions have demonstrated improv
Page 99 and 100:
not been investigated yet, several
Page 101 and 102:
positively correlated in the autist
Page 103 and 104:
abnormalities are present in brain,
Page 105 and 106:
(tetrahydrobiopterin) were selected
Page 107 and 108:
7 - Autism & Infection - 22 citatio
Page 109 and 110:
micro-organisms. The faecal flora o
Page 111 and 112:
Research Support, U.S. Gov't, P.H.S
Page 113 and 114:
presentation of this syndrome among
Page 115 and 116:
disorder. Yamashita Y, Fujimoto C,
Page 117 and 118:
chronic infection may predispose to
Page 119 and 120:
Streptococcus group A. Vojdani A, C
Page 121 and 122:
provides a detailed analysis of a n
Page 123 and 124:
PMID: 16897390 [PubMed - indexed fo
Page 125 and 126:
syndrome and substance abuse, and a
Page 127 and 128:
to contribute to metal-induced neur
Page 129 and 130:
School of Medical Sciences, Tottori
Page 131 and 132:
Review PMID: 16198633 [PubMed - ind
Page 133 and 134:
diseases in humans. Zinc is redox-i
Page 135 and 136:
Office of Vaccines Research and Rev
Page 137 and 138:
Page 139 and 140:
into ferritin or heme. It is not ye
Page 141 and 142:
9 - Dietary Intervention Studies -
Page 143 and 144:
different peptidases resulting in a
Page 145 and 146:
Mechanisms of non-IgE mediated adve
Page 147 and 148:
Reichelt KL, Knivsberg AM.: Can the
Page 149 and 150:
observations is the opioid-excess t
Page 151 and 152:
Patients with gluten ataxia have an
Page 153 and 154:
Hadjivassiliou M, Grunewald RA, Law
Page 155 and 156:
Carroccio A, Montalto G, Custro N,
Page 157 and 158:
Alberti A, Pirrone P, Elia M, Warin
Page 159 and 160:
Thus, a number of milk protein frag
Page 161 and 162:
Abstract: Institute ofPediatrics, L
Page 163 and 164:
Abstract: Service de Psychopatholog
Page 165 and 166:
times peer week) was effective in i
Page 167 and 168:
Reichelt K.L., Knivsberg A.M., Lind
Page 169 and 170:
terminal tetrapeptides into the lef
Page 171 and 172:
Considerable clinical evidence sugg
Page 173 and 174:
material of the P2 fractionation st
Page 175 and 176:
Huebner FR, Lieberman KW, Rubino RP
Page 177 and 178:
Four aspects of clinical evidence f
Page 179 and 180:
Dohan FC: Wheat "consumption" and h
Page 181 and 182:
from 24 children with autism from o
Page 183 and 184:
matched control group. There was a
Page 185 and 186:
administration on certain disorders
Page 187 and 188:
Page 189 and 190:
Coleman M, Steinberg G, Tippett J,
Page 191 and 192:
Dolske MC, Spollen J, McKay S, Lanc
Page 193 and 194:
and myo-inositol (-13%) concentrati
Page 195 and 196:
cobalamin. This was associated with
Page 197 and 198:
(significantly lower ratio of SAM t
Page 199 and 200:
Fifty-three controlled trials of th
Page 201 and 202:
PMID: 6765503 [PubMed - indexed for
Page 203 and 204:
Liebscher DH, Liebscher DE. About t
Page 205 and 206:
from patients were examined at outs
Page 207 and 208:
National College of Naturopathic Me
Page 209 and 210:
OBJECTIVE: Ionic magnesium (Mg(2+))
Page 211 and 212:
Pfeiffer CC, Braverman ER. Zinc, th
Page 213 and 214:
evidence support a role for omega-3
Page 215 and 216:
Page 217 and 218:
scavenge reactive species, then the
Page 219 and 220:
hyperactivity in patients with ADHD
Page 221 and 222:
esponse to folate deprivation. Expr
Page 223 and 224:
improvement may only become apparen
Page 225 and 226:
Walsh WJ, Glab LB, Haakenson ML. Re
Page 227 and 228:
use other internal or external stan
Page 229 and 230:
In contrast, therapy with very high
Page 231 and 232:
increased in affected children comp
Page 233 and 234:
largely unknown, but genetic, envir
Page 235 and 236:
Campbell DB, Sutcliffe JS, Ebert PJ
Page 237 and 238:
OBJECTIVE: Etiologically unexplaine
Page 239 and 240:
globulin and gamma globulins, IgA,
Page 241 and 242:
Fallon J. Could one of the most wid
Page 243 and 244:
Th1-like (IL-2, IFN-gamma) and Th2-
Page 245 and 246:
Jyonouchi H, Geng L, Ruby A, Reddy
Page 247 and 248:
that may be partly associated with
Page 249 and 250:
Department of Neurology, University
Page 251 and 252:
Mehler MF, Kessler JA. Cytokines in
Page 253 and 254:
Niehus R, Lord C. Early medical his
Page 255 and 256:
Pletnikov MV, Jones ML, Rubin SA, M
Page 257 and 258:
Silva SC, Correia C, Fesel C, Barre
Page 259 and 260:
cytokines were measured using speci
Page 261 and 262:
sera) and cerebellum (9% positive s
Page 263 and 264:
Department of Psychiatry, Indiana U
Page 265 and 266:
(DSM)-IV and the International Clas
Page 267 and 268:
Vojdani A, Campbell AW, Anyanwu E,
Page 269 and 270:
Warren RP, Cole P, Odell JD, Pingre
Page 271 and 272:
mechanisms in children with autism.
Page 273 and 274:
12 - Environmental Toxicities (4 ci
Page 275 and 276:
13 - Thimerosal and Toxicity A comp
Page 277 and 278:
Page 279 and 280:
Eye Contact Lens. 2007 Jul;33(4):19
Page 281 and 282:
[Contact allergy to preservatives c
Page 283 and 284:
Marn-Pernat A, Buturović-Ponikvar
Page 285 and 286:
[Thiomersal and immunisations] Weis
Page 287 and 288:
50: The evidence for the safety of
Page 289 and 290:
59: Thimerosal induces DNA breaks,
Page 291 and 292:
68: [Effect of the preservative thi
Page 293 and 294:
Page 295 and 296:
Mutat Res. 1993 May;287(1):29-46. P
Page 297 and 298:
Krug HF, Culig H. Mol Pharmacol. 19
Page 299 and 300:
Effect of organic and inorganic mer
Page 301 and 302:
Determination of mercury and organo
Page 303 and 304:
Cytotoxicity of mercurial preservat
Page 305 and 306:
Bourdineaud JP, Bellance N, Bénard
Page 307 and 308:
14: Binstock Citations Controversie
Page 309 and 310:
neurodevelopmental delays, which in
Page 311 and 312:
14. Geier DA, Geier MR. A comparati
Page 313 and 314:
29. Boyd Haley, Ph.D. Reduced Level
Page 315 and 316:
40c. Iacono G et al. Intolerance of
Page 317 and 318:
affected children compared with bot
Page 319 and 320: "OBJECTIVE: Intestinal pathology, i
Page 321 and 322: 67. Jeff Bradstreet, M.D. A Case-co
Page 323 and 324: in autistic children. In this curre
Page 325 and 326: 87. Semba RD. Vitamin A and immunit
Page 327 and 328: "These results suggest that large o
Page 329 and 330: 94. Bluhm DP, Summers RS. Plasma vi
Page 331 and 332: neonatal gut is different from that
Page 333 and 334: 108. Thony B et al. Tetrahydrobiopt
Page 335 and 336: "Six chemicals, 2-halopropionic aci
Page 337 and 338: immunological functions in diseases
Page 339 and 340: [Note etiologic connection with thi
Page 341 and 342: 149. Magazzu G, Scoglio R. Gastroin
Page 343 and 344: clinical presentations make celiac
Page 345 and 346: 169a. Hadjivassiliou M et al. Does
Page 347 and 348: 174. Headache and CNS white matter
Page 349 and 350: histology is difficult to interpret
Page 351 and 352: (n=25): marked 4%, moderate 28%, sl
Page 353 and 354: 199. Stubbs EG et al. Autism and co
Page 355 and 356: 205. Gill HS, Guarner F. Probiotics
Page 357 and 358: patients with IBS. Since the fermen
Page 359 and 360: demonstrate that probiotics possess
Page 361 and 362: 237. James Neubrander, M.D. -- Bioc
Page 363 and 364: significantly more frequent in pati
Page 365 and 366: aseline. Physicians reported qualit
Page 367 and 368: http://www.publichealthreports.org/
Page 369: No Trade Name Sanofi Pasteur, Ltd 0
Page 373 and 374: Calculating Aluminum in Vaccines He
Page 375 and 376: 16 - How Much Money is Spent on Vac
Page 377 and 378: consumer information (promotion mat
Page 379 and 380: evidence to the mercury-vaccine-aut
Page 381 and 382: More from Verstraeten (Now working
Page 383 and 384: 18 -Difference between Number of Va
show all

Autism Studies and Related Medical Conditions, January 2009 - TACA

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?